APA (7th ed.) Citation

Li, H., Si, T., Li, R., Xie, X., Liu, Y., Fu, L., . . . Mu, X. (2025). Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial. Cancers, 17(19), 3235. https://doi.org/10.3390/cancers17193235

Chicago Style (17th ed.) Citation

Li, Huikai, et al. "Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial." Cancers 17, no. 19 (2025): 3235. https://doi.org/10.3390/cancers17193235.

MLA (9th ed.) Citation

Li, Huikai, et al. "Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial." Cancers, vol. 17, no. 19, 2025, p. 3235, https://doi.org/10.3390/cancers17193235.